MARK Substrate
CAS No. 847991-34-8
MARK Substrate( —— )
Catalog No. M30539 CAS No. 847991-34-8
MARK Substrate is a MARK substrate peptide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 138 | Get Quote |
|
| 10MG | 214 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMARK Substrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMARK Substrate is a MARK substrate peptide.
-
DescriptionMARK Substrate is a MARK substrate peptide.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number847991-34-8
-
Formula Weight1417.61
-
Molecular FormulaC60H108N18O21
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (70.54 mM)
-
SMILES——
-
Chemical NameSequence:Asn-Val-Lys-Ser-Lys-Ile-Gly-Ser-Thr-Glu-Asn-Leu-Lys
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
H-Phe-Pro-Arg-OH
H-Phe-Pro-Arg-OH
-
MM 07
Apelin biased agonist; exhibits bias for the G protein pathway. Stimulates endothelial NOS phosphorylation and expression, promotes proliferation, and attenuates apoptosis of human pulmonary arterial endothelial cells in vitro. Shows positive inotropic and vasodilatory effects in vivo and improves cardiac structure and function in a model of pulmonary arterial hypertension.
-
D-Luciferin
D-Luciferin is a popular bioluminescent substrate of luciferase in the presence of ATP, used in luciferase-based bioluminescence imaging and cell-based high-throughput screening applications.?
Cart
sales@molnova.com